FPS-ZM1

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFPS-ZM1
Drug Alias NameAlzheimer's disease therapy (University of Rochester)RAGE inhibitors (Socratech)RAGE inhibitors (University of Rochester)FPS2-BMFPS-ZM1
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein inhibitorsAdvanced glycosylation end product-specific receptor antagonistsNeuroprotectants
TargetsBeta amyloid A4 proteinAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsAlzheimer DiseasePulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Rochester
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSocratechUniversity Of Rochester
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseasePulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A